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Introduction 1
Cardiovascular disease (CVD) is a significant and often underappreciated cause of morbidity and 2 mortality in women(1). Pregnancy can often "unmask" CVD in women(2,3). In the estimated 85 3 percent of women who experience a pregnancy during their lifetime, cardiovascular 4 complications during pregnancy and childbirth therefore present an opportunity to assess risk for 5 later CVD(4). Indeed, leveraging early phenotypes to identify those at risk for CVD as soon as 6 possible is an aspirational goal for both precision medicine(5,6) and for primary CVD disease 7 prevention (7, 8) . 8 Peripartum cardiomyopathy (PPCM) and hypertensive disorders of pregnancy (HDP) are 9 two major cardiovascular complications of pregnancy and have been reported to share a common 10 underlying pathophysiology in animal studies (9) (10) (11) . PPCM is characterized by the sudden onset 11 of maternal heart failure presenting either in the last month of pregnancy or in the first five 12 months postpartum. Hypertension in pregnancy is defined as a blood pressure equal to or greater 13 than 140/90 mmHg; gestational onset is defined at or after 20 weeks' gestation (Online Table 2 ). 14 We hypothesized that specific subtypes of PPCM and HDP may carry different CVD 15 risks(12) , (13) . Recent data from a Danish nationwide register-based cohort demonstrated that 16 specific subtypes of HDP (i.e. severe preeclampsia, moderate preeclampsia and gestational 17 hypertension) conferred differing risks of incident cardiomyopathy (14) . Still, prior studies have 18 not fully elucidated the independent risks of PPCM and HDP subtypes on specific CVD 19 outcomes [i.e. myocardial infarction (MI), heart failure (HF), and stroke]. The availability of a 20 large cohort of women directly representative of the general population of California in the 21 California Healthcare Cost and Utilization Project (HCUP) allowed us to determine the risks of 22 PPCM and HDP subtypes along a spectrum of chronicity and severity for subsequent MI, HF, 23 and stroke, while independently adjusting for other demographic and pregnancy-related factors 1 that are known to be associated with later maternal CVD [i.e. gestational diabetes mellitus 2 (GDM), preterm delivery and intrauterine growth restriction (IUGR)](15-17). 3 7 Covariates 1
We adjusted for covariates known to be associated with PPCM, hypertension, CVD, and 2 peripartum morbidity and mortality(21) which could potentially confound the associations we 3 were interested in studying. Covariates included age, race, insurance status, median household 4 income, chronic kidney disease, pre-existing diabetes, obesity, drug abuse, smoking, multiple 5 gestations, as well as each of the exposures. Patients with preexisting (prior to pregnancy) HTN 6 were considered to have baseline chronic hypertension and were included within the HDP 7 variable; therefore, we did not include HTN as a covariate. 8 9
Statistical Analyses 10
Primary analyses. We considered our baseline period in which initial delivery occurred from 11 [2005] [2006] [2007] [2008] [2009] . Follow-up began 6 months after delivery in order to avoid double-counting an 12 exposure and outcome, and it lasted until the end of 2011. Descriptive statistics were performed 13 including n's, means and percentages with standard deviations and interquartile ranges as 14 appropriate among all participants and within PPCM and HDP subtypes. We tested the 15 assumption of proportionality of hazards for PPCM and HDP subtypes and MI, HF, and stroke. 16
We found that one of the five HDP subtypes, de novo preeclampsia, violated the assumption 17 (p=0.02). Therefore, in the case of de novo preeclampsia, our hazard ratio estimates represent an 18 average across the length of study follow-up. We employed multivariable Cox proportional 19 hazards models to determine the association between PPCM and HDP and subsequent CVD, 20 adjusting for the potential confounders listed in the covariates section above. We considered 21 GDM, preterm delivery and IUGR as secondary exposures and considered these in multivariable 22 models adjusting for PPCM and HDP. 23 1 Secondary analyses. It is known that certain pregnancy complications beget further 2 comorbidities: for example, hypertensive disorders of pregnancy can be risk factors for 3 PPCM(14). Overlap. We assessed pregnancy exposures for overlap. Similarly, we assessed for 4 overlap among our CVD outcomes of interest. Finally, since specific subtypes of MI and stroke 5 may be more common in younger individuals and among women, we analyzed outcomes by 6 subtype. For example, we assessed how many of the MI's in our population were due to MICAD 7 vs MINOCA, and how many of the incident strokes were from hemorrhagic versus ischemic 8 versus embolic etiologies. As mentioned above, ICD-9 codes for HF subtypes were not specified 9 in the study cohort. We also considered PPCM as intra-or postpartum in order to determine 10 whether timing of PPCM affected CVD outcomes. Stratification. In addition to our original 11 multivariable Cox proportional hazards model (see Primary analyses), we re-ran the model i) 12 stratifying on quintiles of age rather than using age as a covariate and ii) stratifying by preterm 13 birth and PPCM, preeclampsia and PPCM, and IUGR and PPCM. 14
15
All analyses were performed using SAS version 9.4X. A p-value of 0.05 or less was considered 16 statistically significant. Certification to use de-identified HCUP data was obtained from the 17 University of California, San Francisco Committee on Human Research. No informed consent 18 was required. 19
Results 1
Characteristics of study population. 2
Of the 1,662,045 study participants who delivered from 2005-2009 in HCUP-CA, 3 579,656 (35%) were non-Hispanic white women, 105,489 (6%) were African-American, 4 648,602 (39%) were Hispanic, and 200,908 (12%) were Asian or Pacific Islanders. 20,765 5 (1.2%) of pregnancies were complicated by drug abuse, and 11,248 (0.7%) of pregnancies were 6 complicated by active smoking. 330, 946 deliveries were second pregnancies within the study 7 period. In terms of additional risk factors for cardiovascular complications, 23,108 (1.4%) of 8 pregnant women had pre-existing hypertension, 16,806 (1.0%) had pre-existing diabetes, and 9 538 (0.3%) had chronic kidney disease. Notably, the prevalence of African Americans, chronic 10 HTN, and obesity was higher in the PPCM group than in the general population. The prevalence 11 of Asian and Pacific Islanders was higher in the GDM group. 
Prevalence of pregnancy exposures in study population. 15
There were 558 cases of PPCM, 97 of which were diagnosed before delivery, and 461 of which 16 were diagnosed postpartum. There were 49,114 cases of gestational HTN and 62,162 cases of 17 preeclampsia; broken down by HDP subtypes of interest, there were 12,458 cases of isolated 18 chronic HTN, 43,073 cases of de novo gestational HTN, 56,419 cases of de novo preeclampsia, 19 4,907 pregnancies with both chronic HTN and superimposed gestational HTN, and 5,743 20 pregnancies with chronic HTN and superimposed preeclampsia ( Table 2) . There were 107,636 21 cases of GDM, 23,504 cases of IUGR, and 116,768 cases of preterm birth. Median follow-up 22 time to event was 2.68 years, ranging from 1 day to 6.84 years, resulting in 0.99, 1.23, and 1.02 23 cases of MI, HF, and stroke, respectively, per 1000 person-years. Online Table 3 demonstrates 1 the overlap and correlations among pregnancy exposure categories. Preterm birth and 2 preeclampsia were the most highly correlated (Kendall-Tau correlation coefficient 0.146) 3
whereas IUGR and peripartum cardiomyopathy had the lowest correlation (Kendall-Tau 4 correlation coefficient 0.0017) among pregnancy exposures studied. 5 6
Multivariable models demonstrated associations between exposures and future cardiovascular 7

risk. 8
Among all women hospitalized during pregnancy from 2005-2009, there were 558 subsequent 9
MIs, 3284 subsequent cases of HF, and 973 subsequent strokes. Table 2 shows stroke, MI, and 10 HF event numbers by pregnancy exposure category. Of the 11 330,946 pregnancies (of the total ~1.6 million pregnancies) which were second pregnancies 12 within the study period, 24 had MI (24 of 558), 133 had HF (133 of 3284), and 37 had stroke (37 13 of 973). Using multivariable Cox proportional hazards models adjusting for all exposures and 14 covariates, we found that PPCM was independently associated with a 13.0-fold increased risk of 15 MI (95% CI 4.1-40.9), a 39.2-fold increased risk of HF (95% CI 30.0 -51.9), and a 7.7-fold 16 increased risk of stroke (95% CI 2.4-24.0; Figure 1 ; Table 2 ). The hazard ratios were similar for 17 PPCM diagnosed at or before delivery when compared to PPCM diagnosed in the first five 18 months postpartum (Figure 1) . 19 We investigated cardiovascular risks according to hypertensive disorder of pregnancy 20 subtypes of differing chronicity and severity. We examined five subtypes: chronic hypertension 21 alone, de novo gestational hypertension, de novo preeclampsia, chronic hypertension with 22 superimposed gestational hypertension, and chronic hypertension with superimposed 23 preeclampsia (Online Table 2 ). These subtypes carried a 2.3-6.3-fold increased risk for MI, a 1 2.5-5.4-fold increased risk for HF, and a 1.4-7.6-fold increased risk for stroke ( Figure 2 ; Table  2 2). Although there was some overlap in 95% confidence intervals, chronic HTN alone, and with 3 superimposed preeclampsia, carried the highest risks of MI, HF and stroke compared with other 4 HDP subtypes. Chronic HTN with superimposed gestational hypertension did not demonstrate a 5 statistically significant increased risk for MI; the n in this group was less than 10. 6
All of our models included additionally included GDM, preterm birth, and IUGR. IUGR 7 was related to risk of MI but not HF or stroke [HR for MI=1.6 (95% CI: 1.0-2.5)]. Preterm 8 delivery was significantly associated with MI, stroke and HF ( Figure 2 ; Table 2 ). GDM was 9 associated with risks of stroke and HF but not with MI ( Figure 2 ; Table 2 ). Overall, these three 10 pregnancy exposures conferred comparatively lower risks for cardiovascular diseases as 11 compared to PPCM and HDP. 12 13
Tests for residual confounding in the multivariable model show robust associations between 14 exposures and outcomes. 15
Age is a well-known and strong predictor both for both cardiovascular complications of 16 pregnancy and for our outcomes of interest; (21,22) and increased prevalence of exposures and 17 outcomes by age was again demonstrated in our study (Online Table 4 ). We therefore sought to 18 test for residual confounding by age in our multivariable model. We compared hazard ratios 19
derived from our original model to those obtained using an alternate approach stratifying on 20 quintiles of age rather than using age as a covariate (thereby avoiding the assumptions of the 21 proportional hazards model). We found that this alternate approach did not change hazard ratio 22 point estimates or 95% confidence intervals by more than a point (data not shown). 23
We also ran additional models stratifying by preterm birth and PPCM, preeclampsia and 1 PPCM, and IUGR and PPCM, and did not find substantial differences in hazard ratio point 2 estimates or 95% confidence intervals (data not shown). Overlap among all other categories ranged from 1.49% to 10.6% (Online Table 3 ). 10
With respect to outcomes, PPCM is known to be a risk factor for HF but has not 11 previously been described as a risk factor for MI or stroke (Figure 1, Table 2 ). To determine 12 whether there was overlap in MI, HF, and stroke outcome diagnoses in patients with PPCM that 13 might explain our observations, we queried ICD-9 diagnoses for each individual patient in the 14 PPCM exposure group. Most categories of overlap had fewer than 10 patients; for example, 15 fewer than 10 out of 58 patients with PPCM (6.9%) had overlapping outcome diagnoses (for 16 HF/stroke and HF/MI). No single PPCM exposure had all three outcome diagnoses. Among 17 patients with hypertensive disorder of pregnancy subtypes, GDM, preterm birth, and IUGR 18 exposures, the percentage of patients with more than one outcome diagnosis ranged from 5.74% 19 to 11.37%. Therefore, the majority of observed outcomes were separate cardiovascular events. 20
We then asked whether heart failure could be a mediator of MI and stroke among patients 21 with PPCM and overlapping outcome diagnoses. We re-fitted our MI and stroke models with 22 heart failure as a time-dependent covariate. With heart failure as a mediator, the risk of PPCM 23 for MI decreased from 13.0 (95% CI 4.1-40.9) to 4.6 (95% CI 1.4-14.8) and the risk of PPCM 1 for stroke decreased from 7.6 (95% CI) to not significant (2.7 95% CI 0.8-8.5). Therefore, 2 although there were novel significant associations between PPCM and MI and PPCM and stroke, 3 heart failure mediated much of those associations. 4
Finally, we analyzed outcomes by MI and stroke subtypes ( Table 3) . Based on ICD-9 5 coding, we found that the predominant type of MI experienced within the follow-up period was 6 MICAD, and the most common type of stroke was ischemic stroke. 7
Discussion 1
Summary of Findings. 2
In this retrospective cohort study of over 1.6 million deliveries representing nearly every 3 completed pregnancy in California over a 5-year period, we report the following: i) PPCM is 4 associated with risks for MI and stroke in addition to (and partly mediated by) HF; ii) HDP 5 subtypes were associated with risks for MI, stroke, and HF; iii) subtypes of HDP representing a 6 longer duration of hypertension and a higher severity (i.e. chronic HTN and chronic HTN with 7 superimposed preeclampsia) had the greatest magnitudes of risks for MI, stroke and HF; iv) 8 GDM, preterm birth, and IUGR were independently associated with risks for future CVD when 9 accounting for PPCM and HDP; and v) PPCM and HDP were independently associated with 10 CVD when accounting for these other CVD-related pregnancy complications. Stratification by 11 age and by selected exposures did not significantly change observed hazard ratios, suggesting 12 these findings are robust to potential residual confounding. 13
We found that the above cardiovascular pregnancy complications were associated with 14 substantial risks for MI, HF, and stroke even within the first six years post-delivery. In contrast 15 to long-held belief that heart disease largely affects women who are long past their child-bearing 16 years, we demonstrate that the presence of cardiovascular complications of pregnancy can 17 identify a sub-population of younger women who are at high risk for premature cardiovascular 18 disease. Our findings are relevant given the recent call to attention and study concerning the 19 growing epidemic of MI in younger women by scientific experts (7) and support initiatives 20 designed to follow younger at-risk women more closely for CVD prevention(22). 21
PPCM is hypothesized to have several different causes, including genetic mutations, fetal 22 autoimmunity, vascular dysfunction, in addition to HDP itself(23-25). Furthermore, PPCM 23 presenting during pregnancy may represent a different clinical entity as compared to PPCM 1 presenting postpartum(12) and may have different underlying genetic underpinnings(13). Despite 2 this, our findings did not suggest that intrapartum and postpartum PPCM as coded in HCUP 3 conferred differing risks for CVD. Despite overlapping pathophysiology between PPCM and 4 HDP(26), PPCM has a relatively greater magnitude of risk for incident CVD than any of the 5 HDP subtypes studied. 6
Given that preterm birth, IUGR, and GDM have demonstrated associations with 7 CVD(27-29) and are commonly seen with HDP and PPCM, we studied these as secondary 8
exposures and did find that each was significantly associated with one or more subtypes of CVD, 9
confirming findings from prior investigations. HDP is a common reason for medically indicated 10 preterm delivery. Several lines of evidence suggest that a common pathology in many cases of 11 preterm birth and IUGR, as well as subtypes of HDP and PPCM and HDP, is vascular 12 dysfunction of varying chronicity and severity.(30-34) GDM is a risk factor for future diabetes 13 and its attendant microvascular and macrovascular effects(35) which may explain the 14 associations seen between GDM and stroke, as well as HF. 15 16
Strengths and Limitations. 17
As a statewide record, California HCUP provided generalizable data from a large and 18 ethnically diverse population and has been used to uncover several insights into cardiovascular 19 disease(18,36,37). Age, race, and ethnicity in the study cohort were similar to those of national 20 CDC birth records for the same time period (19) . HCUP captures over 95 percent of California's 21 population, which comprises over 38 million people. Large datasets like HCUP can facilitate 22 defining phenotypes at greater resolution, such as the pregnancy complication subtypes analyzed 23 in this paper and in other work from our group(18). In addition to several exposures, we were 1 also able to adjust for several potential confounders, which clarified the effects of each exposure 2 on future cardiovascular risk. Increasing phenotypic resolution at scale can help uncover new 3 associations and inspire new hypotheses on the mechanisms of disease. Here we demonstrate for 4 the first time that PPCM, a relatively rare event, carried risks not only for future HF but also for 5 MI and stroke as well, and that these associations, while mediated in part by HF, are not simply 6 explained by overlap of outcome diagnoses. 7
In terms of magnitude, PPCM conferred the highest magnitude of hazard ratios for future 8 CVD, followed by chronic HTN with superimposed preeclampsia, and then chronic HTN alone. 9
Whereas PPCM and HDP have been demonstrated to exist on a common pathophysiologic 10 spectrum (11, 26) , we demonstrate that their respective association with later cardiovascular 11 disease differ in magnitude of risk. Further basic and translational studies are needed to 12 determine the specific pathophysiologic mechanisms that connect PPCM and HDP with later 13 CVD. 14 Relatively short follow-up time (maximum of 6.84 years) likely resulted in an 15 underestimation of risk along the lifetimes of the individuals studied. Also, with small numbers 16 in some groups after adjustment for several covariates, 95% confidence intervals for several 17 exposure subtypes were wide. Given the significant associations found despite these caveats, the 18 hazard ratios measured in this study may in fact be underestimates of true cardiovascular risk 19 following a pregnancy complicated by PPCM and/or HDP. 20
Despite using a large dataset like HCUP, our analysis of exposure and outcome subtypes 21 were potentially limited due to misclassification bias and to a lack availability of certain 22 diagnostic codes. We attempted to assess the extent of misclassification bias in our study. HCUP 23 data is anonymized, precluding the ability to perform manual chart review of the ICD-9 coding 1 used to define exposures, covariates, and outcomes. We found that prevalence of preterm birth 2 was similar to national estimates; prevalence of PPCM, and GDM were similar to previous 3 reports in smaller California cohorts in which diagnoses were confirmed by manual chart 4 review (19, 21) . Literature review of ICD-9 coding for preeclampsia, gestational HTN, and 5 hypertensive disorders of pregnancy shows low sensitivity and high specificity(38) while ICD-9 6 coding for outcomes like MI, HF, and stroke shows high sensitivity and specificity(39-41). If 7 these trends are also true within HCUP, it would suggest that the hazard ratios reported in this 8 study are likely accurate, but could be underestimates of true risk. Despite these shortcomings, 9
our analysis shows several robust signals indicating increased CVD risk among exposures of 10 interest. 11
Finally, the lack of certain diagnostic codes limited our ability to perform detailed 12 analysis of outcome subtypes (e.g., HF subtypes) or distinguish between HF class. When 13 defining MI and stroke by outcome subtype, there were not enough numbers to perform 14 statistical analysis; the national HCUP database may provide adequate numbers for such an 15 analysis. 16
In this study, we demonstrated that PPCM is associated with near-term HF, MI and stroke 17 in women in California, independent of HDP, GDM, preterm delivery and IUGR. Among HDP 18 subtypes, chronicity and severity of HTN increased risk of subsequent HF, MI and stroke. While 19 these results are independent of age, the increased prevalence of exposures and outcomes with 20 age in the face of national birth patterns with women giving birth at older ages mean that we can 21 expect even more PPCM, HDP, and CVD in pregnant women. The importance of pregnancy as a 22 cardiovascular 'stress test' will, therefore, only further expand in the future. 23 1
Conclusions 2
Our findings support close monitoring of women with cardiovascular pregnancy 3 complications for prevention of subsequent, near-term CVD events and begs further study of 4 potential mechanisms underlying the development of these early CVD events. 5 
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